enmetazobactam [Adjuvant]

Download Sequences


Ontology CARD's Antibiotic Resistance Ontology
Accession ARO:3007171
DefinitionEnmetazobactam is a beta-lactamase inhibitor which exhibits activity against class A extended spectrum beta-lactamases. It is currently in clinical trials in combination with cefepine for the treatment of urinary tract infections and acute pyelonephritis.
SMILESC[n+]1ccn(C[C@@]2(C)[C@H](C(=O)[O-])N3C(=O)C[C@H]3S2(=O)=O)n1
PubChem23653540
ChEMBLCHEMBL4458276
Classification5 ontology terms | Show
Parent Term(s)3 ontology terms | Show
+ is_small_molecule_inhibitor_of TEM-116
+ is_small_molecule_inhibitor_of OXA-10
+ beta-lactam derived beta-lactamase inhibitor
Sub-Term(s)
1 ontology terms | Show
+ cefepime-enmetazobactam [Antibiotic+Adjuvant] has_part
Publications

Lang PA, et al. 2022. Proc Natl Acad Sci U S A 119(18):e2117310119 Studies on enmetazobactam clarify mechanisms of widely used β-lactamase inhibitors. (PMID 35486701)

Bernhard F, et al. 2020. Antimicrob Agents Chemother 64(6): Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model. (PMID 32253212)

Curator Acknowledgements
Curator Description Most Recent Edit